Can microvolt T-wave alternans testing reduce unnecessary defibrillator implantation?

Nature Clinical Practice Cardiovascular Medicine

Volumn 2, Issue 10, 2005, Pages 522-528

  Armoundas, Antonis A ^a   Hohnloser, Stefan H ^b   Ikeda, Takanori ^c   Cohen, Richard J ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GOETHE UNIVERSITY   (Germany)

^c KYORIN UNIVERSITY   (Japan)

^d Massachusetts Institute of Technology Cambridge   (United States)

Author keywords

Alternans; Implantable cardioverter defibrillator; Primary prevention; Sudden cardiac death

Indexed keywords

ACCURACY; CARDIOVASCULAR RISK; CLINICAL TRIAL; DEFIBRILLATION; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; HEALTH CARE COST; HEART DEATH; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; MORTALITY; OUTCOMES RESEARCH; PREDICTION; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; SUDDEN DEATH; T WAVE;

CLINICAL TRIALS; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART FAILURE, CONGESTIVE; HUMANS; STROKE VOLUME; TACHYCARDIA, VENTRICULAR;

EID: 27944432131     PISSN: 17434297     EISSN: 17434300     Source Type: Journal    
DOI: 10.1038/ncpcardio0323     Document Type: Review

References (30)

1. Moss AJ et al. (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346: 877-883
2. Buxton AE et al. (2000) Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 342: 1937-1945
3. Bardy GH et al. (2005) Amiarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352: 225-237
4. AHA American Heart Association: Heart Disease and Stroke Statistics-2005 Update [http://www.americanheart.org/downloadable/heart/ 1105390918119HDSStats2005Update.pdf] (accessed 17 August 2005)
5. Redfield MM et al. (2003) Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic. JAMA 289: 194-202
6. Kadish A (2005) Prophylactic defibrillator implantation - toward an evidence-based approach. N Engl J Med 352: 285-287
7. Pavia S and Wilkoff B (2001) The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr Opin Cardiol 16: 66-71
8. Bigger JT (2002) Expanding indications for implantable cardiac defibrillators. N Engl J Med 346: 931-933
9. Hohnloser SH et al. (2004) Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351: 2481-2488
10. Lewis T (1910) Notes upon alternation of the heart. Q J Med 4: 141-144
11. Smith JM and Cohen RJ (1984) Simple finite-element model accounts for wide range of cardiac dysrhythmias. Proc Natl Acad Sci USA 81: 33-37
12. Smith JM et al. (1988) Electrical alternans and cardiac electrical instability. Circulation 77: 110-121
13. Nearing BD et al. (1991) Dynamic tracking of cardiac vulnerability by complex demodulation of the T wave. Science 252: 437-440
14. Gold MR et al. (2000) A comparison of T-wave alternans, signal averaged electrocardiography and programmed ventricular stimulation for arrhythmia risk stratification. J Am Coll Cardiol 36: 2247-2253
15. Rosenbaum DS et al. (1994) Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 330: 235-241
16. Restivo M et al. (2004) Spatial dispersion of repolarization is a key factor in the arrhythmogenicity of long QT syndrome. J Cardiovasc Electrophysiol 15: 323-331
17. Bloomfield DM et al. (2002) Interpretation and classification of microvolt T-wave alternans tests. J Cardiovasc Electrophysiol 13: 502-512
18. Bloomfield DM et al. (2004) Microvolt T-wave alternans distinguishes between patients likely and patients not likely to benefit from implanted cardiac defibrillator therapy. A solution to the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II conundrum. Circulation 110: 1885-1889
19. Armoundas AA et al. (1998) Prognostic significance of electrical alternans versus signal averaged electrocardiography in predicting the outcome of electrophysiological testing and arrhythmia-free survival. Heart 80: 251-256
20. Klingenheben T et al. (2000) Predictive value of T-wave alternans for arrhythmic events in patients with congestive heart failure. Lancet 356: 651-652
21. Hohnloser SH et al. (2003) Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: Results from a prospective observational study. J Am Coll Cardiol 41: 2220-2224
22. Kitamura H et al. (2002) Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in nonischemic dilated cardiomyopathy. J Am Coll Cardiol 39: 295-300
23. Adachi K et al. (2001) Risk stratification for sudden cardiac death in dilated cardiomyopathy using microvolt-level T-wave alternans. Jpn Circ J 65: 76-80
24. Grimm W et al. (2003) Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation 108: 2883-2891
25. Ikeda T et al. (2000) Combined assessment of T-wave alternans and late potentials used to predict arrhythmic events after myocardial infarction. A prospective study. J Am Coll Cardiol 35: 722-730
26. Ikeda T et al. (2002) T-wave alternans as a predictor for sudden cardiac death after myocardial infarction. Am J Cardiol 89: 79-82
27. Hohnloser SH et al. (2003) T-wave alternans negative coronary patients with low ejection and benefit from defibrillator implantation. Lancet 362: 125-126
28. Chow T et al. (2003) Microvolt T-wave alternans identifies MADIT II type patients at low risk of ventricular tachyarrhythmic events. [abstract] Circulation IV: 323
29. Costantini O et al. (2004) Patients with a nonischemic cardiomyopathy and a negative T-wave alternans stress test are at a low risk of death. Circulation 110 (Suppl 111): 667
30. Raeder EA et al. (1992) Alternating morphology of the QRST complex preceding sudden death. N Engl J Med 326: 271-272